Clinical trial
Study of Etoposide in Breast Cancer Patients
NCT00026949 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026949 |
|---|---|
| Title | Study of Etoposide in Breast Cancer Patients |
| Official title | Pharmacokinetics of Etoposide in Patients With Breast Cancer Receiving High-Dose Etoposide |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 33 |
| Start date | Aug 1, 1999 |
| Completion | Aug 1, 2004 |
| First posted | Nov 15, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: